BioCentury
ARTICLE | Distillery Therapeutics

Cancer

January 23, 2018 10:21 PM UTC

Cell culture studies identified a theophylline-based NUDT5 inhibitor that could help treat breast cancer. High throughput screening of small molecule libraries, testing in vitro and optimization of a ...

BCIQ Company Profiles

Karolinska Institute

BCIQ Target Profiles

Nudix hydrolase 5 (NUDT5)